161 related articles for article (PubMed ID: 31836682)
1.
Eiber M; Kroenke M; Wurzer A; Ulbrich L; Jooß L; Maurer T; Horn T; Schiller K; Langbein T; Buschner G; Wester HJ; Weber W
J Nucl Med; 2020 May; 61(5):696-701. PubMed ID: 31836682
[No Abstract] [Full Text] [Related]
2. The superior detection rate of total-body [
Wang Y; Dong L; Zhao H; Li L; Huang G; Xue W; Liu J; Chen R
Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2484-2494. PubMed ID: 38514483
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Performance and Safety of Positron Emission Tomography with
Surasi DS; Eiber M; Maurer T; Preston MA; Helfand BT; Josephson D; Tewari AK; Somford DM; Rais-Bahrami S; Koontz BF; Bostrom PJ; Chau A; Davis P; Schuster DM; Chapin BF;
Eur Urol; 2023 Oct; 84(4):361-370. PubMed ID: 37414702
[TBL] [Abstract][Full Text] [Related]
4. Presurgical
Djaïleb L; Armstrong WR; Thompson D; Gafita A; Farolfi A; Rajagopal A; Grogan TR; Nguyen K; Benz MR; Hotta M; Barbato F; Ceci F; Schwarzenböck SM; Unterrainer M; Zacho HD; Juarez R; Cooperberg M; Carroll P; Washington S; Reiter RE; Eiber M; Herrmann K; Fendler WP; Czernin J; Hope TA; Calais J
Eur Urol; 2023 Dec; 84(6):588-596. PubMed ID: 37482512
[TBL] [Abstract][Full Text] [Related]
5. Predicting
Lee KH; Mena E; Shih J; Lindenberg L; Wood BJ; Pinto PA; Patel KR; Citrin DE; Choyke PL; Turkbey B
Acad Radiol; 2024 Apr; 31(4):1419-1428. PubMed ID: 37775447
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of PSMA-based
Mena E; Lindenberg ML; Shih JH; Adler S; Harmon S; Bergvall E; Citrin D; Dahut W; Ton AT; McKinney Y; Weaver J; Eclarinal P; Forest A; Afari G; Bhattacharyya S; Mease RC; Merino MJ; Pinto P; Wood BJ; Jacobs P; Pomper MG; Choyke PL; Turkbey B
Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):4-11. PubMed ID: 28894899
[TBL] [Abstract][Full Text] [Related]
7. Combination of [
Kim J; Lee S; Kim D; Kim HJ; Oh KT; Kim SJ; Choi YD; Giesel FL; Kopka K; Hoepping A; Lee M; Yun M
Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1763-1772. PubMed ID: 38200396
[TBL] [Abstract][Full Text] [Related]
8. A bicentric retrospective study of the correlation of EAU BCR risk groups with
Poterszman N; Merlin C; Margail C; Ouvrard E; Imperiale A; Somme F
Sci Rep; 2024 May; 14(1):10908. PubMed ID: 38740809
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Performance and Safety of
Jani AB; Ravizzini GC; Gartrell BA; Siegel BA; Twardowski P; Saltzstein D; Fleming MT; Chau A; Davis P; Chapin BF; Schuster DM;
J Urol; 2023 Aug; 210(2):299-311. PubMed ID: 37126069
[TBL] [Abstract][Full Text] [Related]
10. 18F-DCFBC Prostate-Specific Membrane Antigen-Targeted PET/CT Imaging in Localized Prostate Cancer: Correlation With Multiparametric MRI and Histopathology.
Turkbey B; Mena E; Lindenberg L; Adler S; Bednarova S; Berman R; Ton AT; McKinney Y; Eclarinal P; Hill C; Afari G; Bhattacharyya S; Mease RC; Merino MJ; Jacobs PM; Wood BJ; Pinto PA; Pomper MG; Choyke PL
Clin Nucl Med; 2017 Oct; 42(10):735-740. PubMed ID: 28806263
[TBL] [Abstract][Full Text] [Related]
11. Impact of
Bluemel C; Linke F; Herrmann K; Simunovic I; Eiber M; Kestler C; Buck AK; Schirbel A; Bley TA; Wester HJ; Vergho D; Becker A
EJNMMI Res; 2016 Dec; 6(1):78. PubMed ID: 27785766
[TBL] [Abstract][Full Text] [Related]
12. Radiohybrid Ligands: A Novel Tracer Concept Exemplified by
Wurzer A; Di Carlo D; Schmidt A; Beck R; Eiber M; Schwaiger M; Wester HJ
J Nucl Med; 2020 May; 61(5):735-742. PubMed ID: 31862804
[TBL] [Abstract][Full Text] [Related]
13. True-Positive
Fleming MT; Hermsen R; Purysko AS; Chau A; Davis P; Chapin BF; Schuster DM
J Nucl Med; 2024 May; ():. PubMed ID: 38782456
[No Abstract] [Full Text] [Related]
14. Detection support of lesions in patients with prostate cancer using
Tsuchiya N; Kimura K; Tateishi U; Watabe T; Hatano K; Uemura M; Nonomura N; Shimizu A
Int J Comput Assist Radiol Surg; 2024 Apr; 19(4):613-623. PubMed ID: 38329565
[TBL] [Abstract][Full Text] [Related]
15. Spatial Pattern of Intraprostatic Recurrence after Definitive External-Beam Radiation Therapy for Prostate Cancer: Implications for Focal Boost to Intraprostatic Dominant Lesion.
Aizawa R; Otani T; Ogata T; Moribata Y; Kido A; Akamatsu S; Goto T; Masui K; Sumiyoshi T; Kita Y; Kobayashi T; Nakamoto Y; Mizowaki T
Adv Radiat Oncol; 2024 Jun; 9(6):101489. PubMed ID: 38681892
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Performance and Safety of
Mai Z; Zhou Z
J Urol; 2023 Sep; 210(3):410-411. PubMed ID: 37345476
[No Abstract] [Full Text] [Related]
17. Diagnostic Accuracy of
Dullea A; O'Sullivan L; O'Brien KK; Carrigan M; Ahern S; McGarry M; Harrington P; Walsh KA; Smith SM; Ryan M
Semin Nucl Med; 2024 Jun; ():. PubMed ID: 38906759
[TBL] [Abstract][Full Text] [Related]
18. 68 Ga-PSMA-11 PET/CT in Cherry Hemangiomas.
Betech-Antar V; Urtasun-Iriarte C; Rosales JJ; Barrio-Piqueras M; Rodriguez-Fraile M
Clin Nucl Med; 2024 May; ():. PubMed ID: 38758528
[TBL] [Abstract][Full Text] [Related]
19. 'Case of the Month' from the Department of Urology, Oxford University Hospitals, Oxford, UK: stereotactic radiotherapy to the vas deferens for PSMA-PET CT detected local recurrence 10 years after radical prostatectomy.
Bates AS; Sharma AD; Camilleri P; Browning L; Verrill C; Hamdy FC
BJU Int; 2024 Apr; ():. PubMed ID: 38644731
[No Abstract] [Full Text] [Related]
20. Correction to: Development and validation of [18 F]-PSMA-1007 PET-based radiomics model to predict biochemical recurrence-free survival following radical prostatectomy.
Li T; Xu M; Yang S; Wang G; Liu Y; Liu K; Zhao K; Su X
Eur J Nucl Med Mol Imaging; 2024 May; ():. PubMed ID: 38787398
[No Abstract] [Full Text] [Related]
[Next] [New Search]
